You C, Zhang J, Lei J, Fu W, et al. Cost-effectiveness of perioperative durvalumab plus neoadjuvant chemotherapy for muscle invasive bladder cancer in the United States. Ther Adv Med Oncol 2025;17:17588359251357519.
PMID: 40755829